Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis
- 30 August 2016
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 90 (6), 1226-1237
- https://doi.org/10.1016/j.kint.2016.07.008
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- YB-1 Is an Early and Central Mediator of Bacterial and Sterile Inflammation In VivoThe Journal of Immunology, 2013
- Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejectionEuropean Journal of Cell Biology, 2012
- Notch‐3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injuryThe Journal of Pathology, 2012
- MAPK and PI3K/AKT mediated YB‐1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loopExperimental Dermatology, 2012
- A Novel Small Compound That Promotes Nuclear Translocation of YB-1 Ameliorates Experimental Hepatic Fibrosis in MiceOnline Journal of Public Health Informatics, 2011
- A Conserved Stem Loop Motif in the 5′Untranslated Region Regulates Transforming Growth Factor-β1 TranslationPLOS ONE, 2010
- Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapyBreast Cancer Research, 2007
- Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ EffectsOnline Journal of Public Health Informatics, 2006
- The Y-box Binding Protein YB-1 Suppresses Collagen α1(I) Gene Transcription via an Evolutionarily Conserved Regulatory Element in the Proximal PromoterOnline Journal of Public Health Informatics, 2001
- A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent TranscriptionOnline Journal of Public Health Informatics, 1998